Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 2/20 | 0.46 |
| ▸ | MMP12 | P39900 | 2/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.44 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.44 |
| ▸ | PLK1 | P53350 | 11/20 | 0.43 |
| ▸ | PLK3 | Q9H4B4 | 7/20 | 0.43 |
| ▸ | PTGES | O14684 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.38 |
| ▸ | MMP9 | P14780 | 1/20 | 0.37 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7077937 | 0.96 | PTGES (0.42) | MMP2MMP12FFAR1FFAR4PLK1 | |
| SCHEMBL7083554 | 0.90 | MMP2 (0.47) | MMP2MMP12FFAR1FFAR4PLK1 | |
| SCHEMBL7080234 | 0.87 | MMP2 (0.43) | MMP2MMP12FFAR1FFAR4PLK1 | |
| SCHEMBL7049852 | 0.83 | PTGES (0.58) | PTGESCA1CA2 | |
| SCHEMBL7051034 | 0.81 | PTGES (0.49) | MMP2MMP12PLK1PLK3PTGES | |
| SCHEMBL7048492 | 0.80 | PTGES (0.50) | MMP2MMP12PLK1PLK3PTGES | |
| SCHEMBL7077922 | 0.78 | PLK1 (0.43) | PLK1PLK3CA1CA2PTPN1 | |
| SCHEMBL7077925 | 0.78 | PLK1 (0.43) | PLK1PLK3CA1CA2PTPN1 | |
| SCHEMBL7048197 | 0.77 | PTGES (0.49) | MMP2MMP12PLK1PLK3PTGES | |
| SCHEMBL7076246 | 0.76 | CA1 (0.41) | PLK1PLK3CA1CA2TRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030162818-A1 | Acylsulfonamide derivative | AJINOMOTO CO. INC. (JP) | 2003-08-28 | — | — | US | disclosed |
| US-6555584-B1 | Acetyl-coa carboxylase inhibitors | AJINOMOTO CO., INC. (JP) | 2003-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030162818-A1 | Acylsulfonamide derivative | ACSS2, ACACA, FASN | MMP2 1940/4885MMP12 1603/4885FFAR1 89/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.